Neuropathic Pain Clinical Trials

115 recruitingLast updated: June 6, 2026

There are 115 actively recruiting neuropathic pain clinical trials across 28 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Miami, Florida, United States, Boston, Massachusetts, United States, San Antonio, Texas, United States. Updated daily from ClinicalTrials.gov.


Neuropathic Pain Trials at a Glance

115 actively recruiting trials for neuropathic pain are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 54 trials, with the heaviest enrollment activity in Miami, Boston, and San Antonio. Lead sponsors running neuropathic pain studies include Afyonkarahisar Health Sciences University, Centre Hospitalier Universitaire de Saint Etienne, and University Hospital, Clermont-Ferrand.

Browse neuropathic pain trials by phase

Treatments under study

About Neuropathic Pain Clinical Trials

Looking for clinical trials for Neuropathic Pain? There are currently 82 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuropathic Pain trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuropathic Pain clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 115 trials

Recruiting
Not Applicable

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

Peripheral neuropathic painCancer Survivors
Institut du Cancer de Montpellier - Val d'Aurelle70 enrolled1 locationNCT06834685
Recruiting
Not Applicable

tACS for Neuropathic Pain Management After SCI

Neuropathic Pain Management
The University of Texas Health Science Center, Houston14 enrolled1 locationNCT06029075
Recruiting
Phase 2

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated300 enrolled47 locationsNCT06619860
Recruiting
Phase 1Phase 2

Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

Chronic Neuropathic Pain
Sangamo Therapeutics27 enrolled11 locationsNCT06980948
Recruiting
Phase 2

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Chemotherapy Induced Neuropathic PainChemotherapy Induced Pain NeuropathyChemotherapy Induced Pain
Dogwood Therapeutics Inc.240 enrolled25 locationsNCT06848348
Recruiting

Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study

Neuropathic Pain
VA Office of Research and Development40 enrolled1 locationNCT05811312
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated734 enrolled75 locationsNCT07231419
Recruiting
Not Applicable

Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.

Patients With Taxane-induced Chronic Neuropathic Pain
Hospital Ambroise Paré Paris50 enrolled1 locationNCT07602387
Recruiting
Not Applicable

Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis

Adhesive CapsulitisShoulder PainNeuropathic Pain+3 more
Konya Beyhekim Training and Research Hospital120 enrolled1 locationNCT07493226
Recruiting
Not Applicable

USG-Guided Shoulder Injections in Frozen Shoulder

Adhesive CapsulitisShoulder PainNeuropathic Pain+2 more
Konya Beyhekim Training and Research Hospital68 enrolled1 locationNCT07493213
Recruiting
Not Applicable

Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury

Spinal Cord InjuryNeuropathic PainCalcitonin
Tanta University126 enrolled1 locationNCT05805683
Recruiting
Not Applicable

rTMS Efficacy Coupled With Mirror Therapy

Neuropathic Pain
Centre Hospitalier Universitaire de Saint Etienne64 enrolled2 locationsNCT04867187
Recruiting
Not Applicable

Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.

Neuropathic PainRehabilitation ExerciseSpinal Cord Stimulation (SCS)+2 more
Oslo University Hospital10 enrolled1 locationNCT07403331
Recruiting
Not Applicable

Non-invasive Personalized Transcranial Cortical Neurostimulation for Pain Relief

Drug-resistant Neuropathic Pain
Hospices Civils de Lyon50 enrolled1 locationNCT06209645
Recruiting
Not Applicable

Thalamic-Burst-DBS for Neuropathic Pain

Neuropathic PainCentral Post-stroke Pain
Insel Gruppe AG, University Hospital Bern20 enrolled1 locationNCT05204472
Recruiting
Phase 1Phase 2

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
Florida A&M University20 enrolled1 locationNCT07298408
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated1,100 enrolled76 locationsNCT06628908
Recruiting
Not Applicable

Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Neuropathic PainCorneal Disease
Singapore Eye Research Institute20 enrolled1 locationNCT07566806
Recruiting
Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

painful peripheral neuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Diabetic Peripheral Neuropathic Pain (DPN)+1 more
University of Rochester190 enrolled7 locationsNCT06614322
Recruiting
Phase 2

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

diabetic neuropathic painChronic Low-back PainOsteoarthritis, Knee
Eli Lilly and Company10,000 enrolled64 locationsNCT05986292